---

---

tags : Disease    symbols : GLAXF   

save search

---

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -3.33% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -0.29% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 12.33% | O: 0.87% H: 0.21% C: -2.23%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| -1.93% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $731.33 0.69% 0.0% 2.3M |

Health Technology

| -1.57% | O: 0.38% H: 2.44% C: 1.54%
VRTX | $400.07 1.47% 1.45% 1.3M |

Health Technology

| -4.44% | O: 0.56% H: 0.49% C: -0.12%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| 0.23% | O: -1.1% H: 0.0% C: 0.0%
BIIB | $194.1 -0.14% -0.15% 1.1M |

Health Technology

| -14.36% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 14.91% | O: 0.28% H: 0.93% C: 0.75%
AMGN | News | $271.98 1.13% 1.12% 2.1M |

Health Technology

| -6.39% | O: -0.21% H: 0.34% C: 0.07%
disease report treatment expansion global infections market

---

Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 14.62% | O: 1.64% H: 0.0% C: -1.33%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -2.27% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 11.73% | O: -0.03% H: 0.28% C: -0.41%
LLY | News | $731.33 0.69% 0.0% 2.3M |

Health Technology

| 25.47% | O: 0.99% H: 0.0% C: 0.0%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 16.13% | O: 0.26% H: 0.0% C: 0.0%
DNLI | $15.99 -0.06% -0.06% 3.1M |

Health Technology

| -13.75% | O: 0.05% H: 5.74% C: 3.18%
BIIB | $194.1 -0.14% -0.15% 1.1M |

Health Technology

| -15.45% | O: 0.42% H: 2.37% C: 1.45%
disease parkinson's revenue research therapeutics market

---

Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight
Published: 2023-11-16 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 18.37% | O: -2.04% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.22% | O: 1.01% H: 0.0% C: -2.65%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 2.71% | O: 0.67% H: 0.0% C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 0.75% | O: 0.91% H: 0.21% C: -0.01%
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| -0.26% | O: 0.78% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 17.86% | O: 1.05% H: 1.44% C: 1.15%
ABT | News | $107.07 -0.2% 0.0% 4.9M |

Health Technology

| 9.31% | O: 2.58% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| 0.47% | O: 1.42% H: 0.0% C: 0.0%
rare disease cell eye market

---

Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 1.75% | O: -1.13% H: 0.0% C: -0.63%
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| -7.8% | O: 0.52% H: 0.57% C: -0.56%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 6.62% | O: -0.5% H: 0.26% C: -0.69%
LLY | News | $731.33 0.69% 0.0% 2.3M |

Health Technology

| 27.46% | O: -1.47% H: 0.0% C: 0.0%
BMY | $49.14 0.43% 0.0% 7.9M |

Health Technology

| -16.4% | O: -0.37% H: 1.54% C: 0.89%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 9.2% | O: -0.04% H: 0.76% C: -0.16%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -16.49% | O: -1.16% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 3.19% | O: 0.19% H: 0.03% C: -1.57%
AMGN | News | $271.98 1.13% 1.12% 2.1M |

Health Technology

| 0.17% | O: 0.22% H: 0.15% C: -0.98%
disease tumor market

---

Inflammatory Bowel Disease Market to grow by USD 7,687.43 million from 2022 to 2027; The increasing demand for biologics and targeted therapies drives the market - Technavio
Published: 2023-08-16 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 20.4% | O: 5.46% H: 0.0% C: -2.87%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 10.07% | O: -0.67% H: 0.0% C: 0.0%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| 0.81% | O: -0.99% H: 1.45% C: 1.36%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -7.62% | O: -0.2% H: 0.34% C: -0.26%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 15.12% | O: -0.77% H: 0.79% C: 0.17%
BAX | $40.4 2.36% 0.0% 3.2M |

Health Technology

| -4.6% | O: -0.4% H: 0.73% C: -0.24%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 10.72% | O: 0.56% H: 0.0% C: 0.0%
ABT | News | $107.07 -0.2% 0.0% 4.9M |

Health Technology

| 1.11% | O: -1.36% H: 0.88% C: 0.07%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -13.05% | O: -1.33% H: 0.0% C: 0.0%
disease market

---

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives Growth
Published: 2023-06-28 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 18.09% | O: 1.75% H: 0.06% C: 0.06%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| -1.19% | O: 1.06% H: 0.72% C: 0.72%
ALPMY | News | $9.5 -1.11% 1M |

Manufacturing

| -37.18% | O: -1.98% H: 0.0% C: -0.47%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -3.73% | O: 0.17% H: 0.85% C: 0.76%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 14.24% | O: -1.21% H: 1.17% C: 0.91%
ABT | News | $107.07 -0.2% 0.0% 4.9M |

Health Technology

| -0.5% | O: -0.54% H: 0.78% C: 0.59%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -14.26% | O: -1.86% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| -1.17% | O: -0.83% H: 0.89% C: 0.68%
lung disease report treatment global growth market

---

Gastrointestinal Drugs Market Research Report by Drug Category, Route of Administration, Disease Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-23 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 13.41% | O: -3.13% H: 0.0% C: -0.23%
TAK | News | $13.36 0.91% -0.52% 1.6M |

Health Technology

| -13.36% | O: 0.13% H: 0.71% C: 0.65%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 14.95% | O: -0.14% H: 0.28% C: -0.11%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -3.75% | O: -0.23% H: 0.0% C: 0.0%
covid-19 drug research global disease report impact gastrointestinal market

---

Addisons disease therapeutics market size to increase by USD 442 million: 41% growth to originate from North America - Technavio
Published: 2022-12-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 14.11% | O: -1.57% H: 2.23% C: 2.23%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 2.42% | O: -0.71% H: 0.08% C: -1.07%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 13.0% | O: 0.36% H: 0.28% C: -1.17%
ABT | News | $107.07 -0.2% 0.0% 4.9M |

Health Technology

| -3.77% | O: -1.27% H: 0.14% C: -1.21%
TECH | $62.79 1.08% 1.07% 830K |

Health Technology

| -27.66% | O: -1.84% H: 0.92% C: -1.2%
BIIB | $194.1 -0.14% -0.15% 1.1M |

Health Technology

| -32.85% | O: -0.51% H: 0.11% C: -1.44%
AMGN | News | $271.98 1.13% 1.12% 2.1M |

Health Technology

| 0.29% | O: -0.25% H: 0.25% C: -1.59%
america disease therapeutics growth market

---

Sexually transmitted disease (STD) testing market size to grow by USD 29,988.27 Million: Increasing prevalence of STDs remains key growth driver - Technavio
Published: 2022-12-07 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 14.62% | O: 1.92% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 10.06% | O: -1.41% H: 1.75% C: 0.66%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 1.51% | O: 0.0% H: 0.5% C: 0.36%
disease growth market

---

Non-steroidal Anti-inflammatory Drugs Market Research Report by Disease Indication, Drugs, Route of Administration, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-07 (Crawled : 16:00) - prnewswire.com
RBGPF | News | $51.75 6.46% 3.6K |

Consumer Non-Durables

| -26.44% | O: 0.06% H: 3.15% C: 0.15%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 7.69% | O: 0.74% H: 0.0% C: -6.74%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -4.51% | O: 1.62% H: 0.0% C: -4.28%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 1.45% | O: -0.56% H: 0.61% C: 0.01%
RBGLY | News | $10.35 -2.05% 500K |

Manufacturing

| -27.39% | O: 0.51% H: 0.48% C: -0.14%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| 2.93% | O: 0.0% H: 0.55% C: -0.27%
ZTS | $145.54 -0.66% 0.0% 4.3M |

Health Technology

| -4.91% | O: -0.06% H: 0.54% C: -1.77%
PRGO | $30.06 -2.4% 0.0% 1.4M |

Health Technology

| -5.26% | O: -0.09% H: 0.47% C: -0.28%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 7.04% | O: -0.98% H: 0.24% C: -1.78%
LLY | News | $731.33 0.69% 0.0% 2.3M |

Health Technology

| 98.44% | O: 0.21% H: 1.6% C: 0.72%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| 2.56% | O: 5.18% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 2.29% | O: 0.45% H: 0.64% C: -0.03%
covid-19 research global disease report impact distribution market

---

The Global Addison's Disease Therapeutics Market is expected to grow by $442 mn from 2023-2027, accelerating at a CAGR of 6.93% during the forecast period
Published: 2022-11-30 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 21.78% | O: -0.06% H: 0.06% C: -1.08%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 30.74% | O: 1.83% H: 0.0% C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 8.48% | O: 1.22% H: 1.37% C: 1.28%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 18.13% | O: 0.09% H: 0.58% C: 0.58%
ABT | News | $107.07 -0.2% 0.0% 4.9M |

Health Technology

| 1.97% | O: 0.12% H: 2.44% C: 2.33%
BIIB | $194.1 -0.14% -0.15% 1.1M |

Health Technology

| -33.39% | O: 5.1% H: 1.83% C: -0.36%
AMGN | News | $271.98 1.13% 1.12% 2.1M |

Health Technology

| -3.57% | O: 0.2% H: 1.91% C: 1.36%
global disease expected therapeutics market

---

Parkinson's Disease Drugs Market to Reach $10.4 Bn, Globally, by 2031 at 6.2% CAGR: Allied Market Research
Published: 2022-11-17 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 24.92% | O: 0.98% H: 0.0% C: 0.0%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| 1.53% | O: -1.62% H: 1.01% C: 0.55%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 13.43% | O: -1.56% H: 1.64% C: 1.47%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 23.34% | O: -2.04% H: 1.21% C: 1.09%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 10.55% | O: -0.59% H: 1.39% C: 0.79%
BIIB | $194.1 -0.14% -0.15% 1.1M |

Health Technology

| -35.3% | O: -0.98% H: 1.97% C: 1.68%
research disease parkinson's market

---

USD 45.37 Mn incremental growth expected in Darier Disease Drugs Market -- Driven by an increase in demand for advanced dermatological diagnosis
Published: 2022-09-29 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 34.62% | O: -3.32% H: 4.73% C: 4.73%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 53.45% | O: 1.87% H: 0.0% C: 0.0%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| 28.87% | O: -1.26% H: 0.7% C: -0.23%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 24.17% | O: 0.17% H: 1.1% C: 0.16%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 37.78% | O: -0.14% H: 0.53% C: -0.2%
BHC | $8.45 -2.76% 0.24% 2.3M |

Health Technology

| 13.12% | O: -1.2% H: 0.0% C: -5.83%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 16.11% | O: 0.17% H: 0.28% C: -1.47%
disease expected dermatological growth market

---

Global Chronic Obstructive Pulmonary Disease Treatment Market to Surpass US$ 25,601.45 Million by 2030 - Coherent Market Insights
Published: 2022-09-08 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 33.46% | O: 2.63% H: 0.0% C: -3.84%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 21.95% | O: 6.1% H: 0.13% C: -1.44%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 42.66% | O: 0.0% H: 0.0% C: -1.42%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 17.09% | O: -0.75% H: 1.17% C: 1.16%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 28.9% | O: -1.84% H: 2.04% C: 1.94%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 17.24% | O: -0.47% H: 1.85% C: 1.31%
treatment global disease market

---

Global Acquired von Willebrand Disease (AvWD) Treatment Market Report 2022-2030 Featuring Key Players - Novo Nordisk A/S, Genentech, Inc., F. Hoffman-La Roche AG, Sanofi SA
Published: 2022-07-25 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -5.58% | O: 0.0% H: 0.0% C: 0.0%
NVO | News | $125.26 2.08% 0.18% 3.6M |

Health Technology

| 9.3% | O: 0.83% H: 0.67% C: 0.32%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| -4.02% | O: 0.76% H: 0.19% C: -1.06%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -6.4% | O: 2.0% H: 0.0% C: 0.0%
treatment global disease report roche acquired sanofi market

---

Breakthroughs In Treating Killer Diseases Could Lengthen Life
Published: 2022-06-07 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -26.18% | O: 0.0% H: 0.86% C: 0.84%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 10.45% | O: 4.83% H: 0.0% C: -5.0%
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| -15.87% | O: -0.18% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| -5.19% | O: 0.37% H: 3.03% C: 2.98%
LLY | News | $731.33 0.69% 0.0% 2.3M |

Health Technology

| 132.42% | O: -3.62% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 10.41% | O: 0.54% H: 2.78% C: 2.69%
life disease

---

Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published: 2022-05-18 (Crawled : 07:00) - prnewswire.com
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 7.55% | O: -0.31% H: 0.53% C: -0.19%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| -8.93% | O: -0.43% H: 0.0% C: 0.0%
BHC | $8.45 -2.76% 0.24% 2.3M |

Health Technology

| -23.53% | O: -0.72% H: 1.09% C: -9.3%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 8.28% | O: -0.17% H: 0.59% C: -1.52%
ACAD | News | $17.0 1.07% 1.06% 1.2M |

Health Technology

| -1.11% | O: -3.61% H: 1.39% C: -3.14%
europe disease growth market

---

USD 438.03 Mn growth expected in Krabbe Disease Treatment Market | North America to emerge as key market | Technavio
Published: 2022-04-28 (Crawled : 16:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| 40.13% | O: 1.95% H: 0.0% C: 0.0%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -28.21% | O: -3.19% H: 1.56% C: 1.56%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 25.9% | O: -0.44% H: 0.0% C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 5.99% | O: -0.38% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| -10.67% | O: -0.59% H: 0.0% C: 0.0%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 7.5% | O: 0.6% H: 0.0% C: 0.0%
america treatment disease growth market

---

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
Published: 2022-04-25 (Crawled : 12:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -38.49% | O: -2.78% H: 0.0% C: 0.0%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -25.95% | O: -0.99% H: 0.0% C: -0.11%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -15.25% | O: 0.27% H: 0.0% C: 0.0%
MNKKQ | $0.02 |

Manufacturing

| -81.52% | O: -2.96% H: 2.29% C: -6.57%
ALPMY | News | $9.5 -1.11% 1M |

Manufacturing

| -40.06% | O: -0.1% H: 0.35% C: -0.09%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| 5.34% | O: -5.01% H: 0.0% C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 4.78% | O: -0.67% H: 0.0% C: 0.0%
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| -18.33% | O: 0.01% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| -10.26% | O: -1.57% H: 1.5% C: 1.39%
BSX | $68.02 1.03% 0.0% 7.6M |

Health Technology

| 46.77% | O: -4.95% H: 2.32% C: 1.9%
BHC | $8.45 -2.76% 0.24% 2.3M |

Health Technology

| -61.82% | O: -3.12% H: 0.37% C: 0.19%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 6.58% | O: -2.17% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -16.09% | O: -2.01% H: 0.0% C: 0.0%
NMRD | $0.084 -28.78% 12K |

Health Technology

| -97.87% | O: 17.02% H: 0.52% C: -2.6%
AMGN | News | $271.98 1.13% 1.12% 2.1M |

Health Technology

| 6.83% | O: -1.38% H: 0.65% C: 0.46%
device disease

---

Gastrointestinal Diseases Therapeutics Market to record USD 22.82 Bn growth | Evolving Opportunities with Abbott Laboratories and AbbVie Inc. | Technavio
Published: 2022-04-15 (Crawled : 11:00) - prnewswire.com
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| Email alert Add to watchlist
BHC | $8.45 -2.76% 0.24% 2.3M |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| Email alert Add to watchlist
ABT | News | $107.07 -0.2% 0.0% 4.9M |

Health Technology

| Email alert Add to watchlist
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| Email alert Add to watchlist
gastrointestinal therapeutics growth market disease

---

Gainers vs Losers

75%

25%

Top 10 Gainers

MTTR | News M | $4.78 174.71% 63.6% 72M |

AGBA | $2.565 105.2% 51.27% 200M |

Finance

MLEC | $2.44 74.29% 42.62% 78M |

n/a

EDBL | News | $6.28 67.02% 40.13% 16M |

ATGL | $2.91 48.81% 32.8% 180K |

ZAPP | $0.2175 47.16% 32.05% 16M |

n/a

ONFO | $0.6075 38.38% 27.74% 7.3M |

n/a

VIVK | $1.48 38.32% 27.7% 530K |

Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.8M |

SDIG A | $3.635 35.13% 26.0% 1M |

---

Your saved searches

---